In vitro Drug Discovery Services

Biopta is a GLP compliant in vitro drug discovery CRO with core expertise in ex vivo isolated tissue pharmacology

Biopta's isolated tissue screening provides rapid feedback on drug potency, efficacy or safety in a range of fresh ex vivo human tissues.

Biopta's assays utilize ethically obtained, fresh tissues to provide human safety or efficacy data much earlier in the development process; accelerating development and reducing the risk of late stage failures.

We deliver a customer focused and flexible service to global pharmaceutical and biotechnology companies, providing both validated assays and tailored research services.  Further details can be found at Contract Research Services.

Accelerating Development, Reducing Risk